Rojjares Netthong

Rojjares Netthong , affiliated with Ubon Ratchathani University’s Department of Pharmacy Practice, holds a PhD in Pharmacy and Pharmaceutical Sciences. With a nine-year background in the field, she has diversified her expertise through an MBA focused on Appreciative Inquiry theory. She has served on the university faculty, managed its pharmacy store, and initiated community pharmacy projects. Recently, completing her Ph.D from the University of Lincoln in 2023, her research aims to advance the smart use of antibiotics in Thailand. Dr. Netthong is well-versed in international healthcare policies, particularly those of the UK. She presented her work in various academic settings, including a national forum on Antimicrobial Resistance in Thailand in 2022. Additionally, she has contributed to the journal “Antibiotics” and maintains an active academic network through platforms such as LinkedIn, ResearchGate, and ORCID.

Publications

Biomedical Applications of Hybrid Nanomaterials
Biomedical Applications of Hybrid Nanomaterials
Bancha Yingngam, Benjabhorn Sethabouppha, Krit Yingngam, Rojjares Netthong, Jeerisuda Khumsikiew, Sisira Donsamak, Abhiruj Navabhatra. © 2024. 56 pages.
The ever-evolving field of nanotechnology has led to groundbreaking advancements in biomedical science, particularly through the development of hybrid nanomaterials. This chapter...
Bibliometric Analysis of Antibacterial Drug Resistance: An Overview
Bibliometric Analysis of Antibacterial Drug Resistance: An Overview
Rojjares Netthong, Jeerisuda Khumsikiew, Sisira Donsamak, Abhiruj Navabhatra, Krit Yingngam, Bancha Yingngam. © 2024. 50 pages.
As the burden of antibacterial drug resistance continues to increase, understanding the landscape of existing research is crucial for navigating future directions and strategies....
Motivations and Barriers to Using Digital Healthcare
Motivations and Barriers to Using Digital Healthcare
Bancha Yingngam, Jeerisuda Khumsikiew, Rojjares Netthong. © 2024. 47 pages.
The digital healthcare industry offers personalized care, expanded access, and improved efficiency. Despite its potential, adoption rates vary across healthcare sectors due to...